Anaxiom Corporation, a clinical-stage medical device company developing a novel, non-surgical treatment for obesity, today announced the successful completion of a 12-patient OUS clinical study. Early ...

The wellness and aesthetics clinic announced a facility expansion and the addition of new non-invasive services to support increased patient demand in Lubbock. The clinic expansion allows us to better ...

Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods. Weight-loss experts spoke with Fox News Digital about ...

An investigational endoscopic procedure showed a trend for reducing weight rebounds after patients with obesity discontinued the GLP-1 agonist tirzepatide (Zepbound), according to preliminary results ...